>> Black Swan Analysis Blog

Black Swan Analysis Blog

Vertex Cystic Fibrosis Drugs approved for NHS use after 3-year financial dispute

On October 29, 2019, Tags Gene Therapy, Medicine

On October the 24th 2019, the NHS reported a licensing agreement with Vertex Pharmaceutical’s range of Cystic Fibrosis (CF) treatments (NHS England, 2019). This comes after a series of failed...

NICE deems Rubraca® cost effective for the NHS to treat Ovarian Cancer

On October 22, 2019, Tags Pricing Strategies, Gene Therapy, Medicine

As of October 11th, Rubraca (Rucaparib) has been approved for NHS use by NICE in its final draft guidance (NICE, 2019). The drug, developed by the University of Newcastle, will benefit women with...

Gene therapies: Are we embarking on a new revolution in medicine?

On November 29, 2018, Tags Gene Therapy

After decades of research and a number of setbacks, gene therapy is finally becoming a reality with the recent approval of three pioneering treatments, including two highly anticipated CAR-T...

1
New Call-to-action

Subscribe to Email Updates

New call-to-action
RX Brochure CTA Large

Recent Posts

Free Brochure Epiomic